Metabolic pathways in T cell activation and lineage differentiation.

Recent advances in the field of immunometabolism support the concept that fundamental processes in T cell biology, such as TCR-mediated activation and T helper lineage differentiation, are closely linked to changes in the cellular metabolic programs. Although the major task of the intermediate metabolism is to provide the cell with a constant supply of energy and molecular precursors for the production of biomolecules, the dynamic regulation of metabolic pathways also plays an active role in shaping T cell responses. Key metabolic processes such as glycolysis, fatty acid and mitochondrial metabolism are now recognized as crucial players in T cell activation and differentiation, and their modulation can differentially affect the development of T helper cell lineages. In this review, we describe the diverse metabolic processes that T cells engage during their life cycle from naïve towards effector and memory T cells. We consider in particular how the cellular metabolism may actively support the function of T cells in their different states. Moreover, we discuss how molecular regulators such as mTOR or AMPK link environmental changes to adaptations in the cellular metabolism and elucidate the consequences on T cell differentiation and function.

[1]  J. Rathmell,et al.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.

[2]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[3]  D. Draper,et al.  The role of apoptosis in the development and function of T lymphocytes , 2005, Cell Research.

[4]  Peter Vogel,et al.  mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.

[5]  Werner Müller,et al.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. , 2011, Immunity.

[6]  M. Hoth,et al.  Mitochondria Positioning Controls Local Calcium Influx in T Cells , 2009, The Journal of Immunology.

[7]  K. Inoki,et al.  AMPK and mTOR in cellular energy homeostasis and drug targets. , 2012, Annual review of pharmacology and toxicology.

[8]  M. Buck,et al.  T cell metabolism drives immunity , 2015, The Journal of experimental medicine.

[9]  P. Toogood,et al.  Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists. , 2015, Nature chemical biology.

[10]  P. Ramírez,et al.  Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation. , 2016, World journal of transplantation.

[11]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[12]  Matias Ostrowski,et al.  Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions , 2014, Front. Immunol..

[13]  B. Tong,et al.  Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway. , 2015, Biochemical pharmacology.

[14]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[15]  Kelley M. Fracchia,et al.  Modulation of T Cell Metabolism and Function through Calcium Signaling , 2013, Front. Immunol..

[16]  L. Figueiredo Faculty Opinions recommendation of HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. , 2017 .

[17]  W. Ellmeier,et al.  The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[19]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[20]  A. Lane,et al.  Regulation of mammalian nucleotide metabolism and biosynthesis , 2015, Nucleic acids research.

[21]  D. Wallace,et al.  Essential role of mitochondrial energy metabolism in Foxp3+ T‐regulatory cell function and allograft survival , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Kristen N. Pollizzi,et al.  Regulation of T cells by mTOR: the known knowns and the known unknowns. , 2015, Trends in immunology.

[23]  E. E. Vincent,et al.  The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. , 2015, Immunity.

[24]  J. Ramos-Martínez,et al.  The regulation of the oxidative phase of the pentose phosphate pathway: New answers to old problems , 2014, IUBMB life.

[25]  D. Sabatini,et al.  An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis , 2015, Cell.

[26]  J. Rathmell,et al.  Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.

[27]  B. Viollet,et al.  AMP‐activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function , 2008, European journal of immunology.

[28]  M. Battaglia,et al.  Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.

[29]  B. Faubert,et al.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability , 2013, Proceedings of the National Academy of Sciences.

[30]  C. Clish,et al.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.

[31]  M. Cho,et al.  Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance , 2015, PloS one.

[32]  Andrea Glasauer,et al.  Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis , 2014, eLife.

[33]  W. Lehmann,et al.  Immunosuppression and Aberrant T Cell Development in the Absence of N-Myristoylation , 2015, The Journal of Immunology.

[34]  U. Sauer,et al.  Real-time metabolome profiling of the metabolic switch between starvation and growth , 2015, Nature Methods.

[35]  E. Wherry,et al.  Regulator of Fatty Acid Metabolism, Acetyl Coenzyme A Carboxylase 1, Controls T Cell Immunity , 2014, The Journal of Immunology.

[36]  Maxim N. Artyomov,et al.  Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation , 2014, Nature Immunology.

[37]  O. Kretz,et al.  Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming , 2016, Cell.

[38]  T. Basak,et al.  Kinetic Mechanisms of Cholesterol Synthesis: A Review , 2011 .

[39]  J. Šmarda,et al.  Low-Glucose Conditions of Tumor Microenvironment Enhance Cytotoxicity of Tetrathiomolybdate to Neuroblastoma Cells , 2013, Nutrition and cancer.

[40]  J. Rathmell,et al.  Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in CD8 versus CD4 T Cells , 2014, PloS one.

[41]  C. Bernstein,et al.  Novel Anti-Inflammatory Action of 5-Aminoimidazole-4-carboxamide Ribonucleoside with Protective Effect in Dextran Sulfate Sodium-Induced Acute and Chronic Colitis , 2010, Journal of Pharmacology and Experimental Therapeutics.

[42]  T. Sparwasser,et al.  Fatty acid metabolism in the regulation of T cell function. , 2015, Trends in immunology.

[43]  Andre E Nel,et al.  T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. , 2002, The Journal of allergy and clinical immunology.

[44]  P. Stover,et al.  One-carbon metabolism-genome interactions in folate-associated pathologies. , 2009, The Journal of nutrition.

[45]  D. Fruman,et al.  Regulation of quiescence in lymphocytes. , 2003, Trends in immunology.

[46]  Zhandong Liu,et al.  Serine catabolism regulates mitochondrial redox control during hypoxia. , 2014, Cancer discovery.

[47]  J. Locasale,et al.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. , 2015, The Journal of clinical investigation.

[48]  K. Frauwirth,et al.  Induction of Glucose Metabolism in Stimulated T Lymphocytes Is Regulated by Mitogen-Activated Protein Kinase Signaling , 2010, PloS one.

[49]  A. Waickman,et al.  mTOR, metabolism, and the regulation of T‐cell differentiation and function , 2012, Immunological reviews.

[50]  Wei-Wei Zhang,et al.  Metformin decreases IL‐22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma , 2014, International journal of cancer.

[51]  Sang Gyun Kim,et al.  Nutrient regulation of the mTOR Complex 1 signaling pathway , 2013, Molecules and cells.

[52]  D. Hardie,et al.  Management of cellular energy by the AMP‐activated protein kinase system , 2003, FEBS letters.

[53]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[54]  Roger J. Davis,et al.  Requirement for Transcription Factor NFAT in Interleukin-2 Expression , 1999, Molecular and Cellular Biology.

[55]  Charles L. Hoppel,et al.  Production of Reactive Oxygen Species by Mitochondria , 2003, Journal of Biological Chemistry.

[56]  J. Mauël,et al.  CD69 and regulation of the immune function. , 1999, Immunopharmacology and immunotoxicology.

[57]  D. Hailey,et al.  Autophagy termination and lysosome reformation regulated by mTOR , 2010, Nature.

[58]  J. T. Babcock,et al.  Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response* , 2013, The Journal of Biological Chemistry.

[59]  F. Andris,et al.  AMPK in Lymphocyte Metabolism and Function , 2015, International reviews of immunology.

[60]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[61]  S. Baroletti,et al.  Everolimus: A Proliferation Signal Inhibitor with Clinical Applications in Organ Transplantation, Oncology, and Cardiology , 2010, Pharmacotherapy.

[62]  D. Iliopoulos,et al.  miRNAs link metabolic reprogramming to oncogenesis , 2013, Trends in Endocrinology & Metabolism.

[63]  Michal Sheffer,et al.  Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. , 2016, Cell metabolism.

[64]  J. Locasale Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.

[65]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[66]  T. Sparwasser,et al.  Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity , 2012, Front. Immun..

[67]  D. Green,et al.  Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis , 2015, Nature Immunology.

[68]  E. Flescher,et al.  Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells. , 1989, Journal of immunology.

[69]  N. Demaurex,et al.  Calcium uptake mechanisms of mitochondria. , 2010, Biochimica et biophysica acta.

[70]  M. Birnbaum,et al.  Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development. , 2018, Immunity.

[71]  M. Hoth,et al.  T cell activation requires mitochondrial translocation to the immunological synapse , 2007, Proceedings of the National Academy of Sciences.

[72]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[73]  T. Horvath,et al.  An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. , 2010, Immunity.

[74]  S. Kliche,et al.  TCR-Induced Activation of Ras Proceeds at the Plasma Membrane and Requires Palmitoylation of N-Ras , 2010, The Journal of Immunology.

[75]  G. Schieven,et al.  Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. , 1994, Journal of immunology.

[76]  T. Sparwasser,et al.  Disruption of de novo fatty acid synthesis via acetyl‐CoA carboxylase 1 inhibition prevents acute graft‐versus‐host disease , 2016, European journal of immunology.

[77]  Kristen N. Pollizzi,et al.  Cellular Size as a Means of Tracking mTOR Activity and Cell Fate of CD4+ T Cells upon Antigen Recognition , 2015, PloS one.

[78]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[79]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[80]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[81]  Linda V. Sinclair,et al.  The cytotoxic T cell proteome and its shaping by mammalian Target of Rapamycin , 2015, Nature Immunology.

[82]  A. Regev,et al.  CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity , 2015, Cell.

[83]  C. Deutsch,et al.  Metabolic changes in activated T cells: An NMR study of human peripheral blood lymphocytes , 1993, Magnetic resonance in medicine.

[84]  C. Bernstein,et al.  AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. , 2010, Biochemical pharmacology.

[85]  Greg M. Delgoffe,et al.  Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8 T cell differentiation , 2016, Nature Immunology.

[86]  Hyoju Yi,et al.  Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. , 2013, International immunopharmacology.

[87]  L. Boros,et al.  Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[88]  M. V. Heiden,et al.  Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells , 2015, Cell.

[89]  R. Heath,et al.  Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. , 2005, Cell metabolism.

[90]  K. Yokote,et al.  Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1. , 2015, Cell reports.

[91]  N. Shapiro,et al.  Mitochondria Are Gate-keepers of T Cell Function by Producing the ATP That Drives Purinergic Signaling* , 2014, The Journal of Biological Chemistry.

[92]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[93]  V. De Rosa,et al.  A key role of leptin in the control of regulatory T cell proliferation. , 2007, Immunity.

[94]  Aristeidis E. Boukouris,et al.  Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. , 2016, Trends in biochemical sciences.

[95]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[96]  M. Birnbaum,et al.  Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. , 2014, Immunity.

[97]  Zhong Yun,et al.  Hypoxic tumor microenvironment and cancer cell differentiation. , 2009, Current molecular medicine.

[98]  A. Waickman,et al.  Mammalian Target of Rapamycin Integrates Diverse Inputs To Guide the Outcome of Antigen Recognition in T Cells , 2012, The Journal of Immunology.

[99]  S. Aichinger,et al.  Cell-cycle-related metabolic and enzymatic events in proliferating rat thymocytes. , 1988, European journal of biochemistry.

[100]  Boquan Jin,et al.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance , 2015, Cellular and Molecular Immunology.

[101]  Shailendra Giri,et al.  5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[102]  T. Schumacher,et al.  Mapping the life histories of T cells , 2010, Nature Reviews Immunology.

[103]  D. Longo,et al.  p70S6K1 in the TORC1 pathway is essential for the differentiation of Th17 Cells, but not Th1, Th2, or Treg cells in mice , 2015, European journal of immunology.

[104]  M. Resh Covalent lipid modifications of proteins , 2013, Current Biology.

[105]  David K. Finlay,et al.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells , 2012, The Journal of experimental medicine.

[106]  C. Benoist,et al.  T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. , 2001, International immunology.

[107]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[108]  T. Finkel,et al.  Fatty acid oxidation in macrophage polarization , 2016, Nature Immunology.

[109]  D. Guertin,et al.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. , 2013, Immunity.

[110]  Jia Xu,et al.  Cross-Talk between AMPK and mTOR in Regulating Energy Balance , 2012, Critical reviews in food science and nutrition.

[111]  Min-jung Park,et al.  Metformin Attenuates Experimental Autoimmune Arthritis through Reciprocal Regulation of Th17/Treg Balance and Osteoclastogenesis , 2014, Mediators of inflammation.

[112]  J. Davies,et al.  Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.

[113]  M. Loriot,et al.  The effect of immunosuppressive molecules on T-cell metabolic reprogramming. , 2016, Biochimie.

[114]  S. Tay,et al.  The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions , 2016, The Journal of Immunology.

[115]  C. Spencer,et al.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. , 2010, Immunity.

[116]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[117]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[118]  Baoshan Xu,et al.  Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells , 2010, Laboratory Investigation.

[119]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[120]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[121]  Linda V. Sinclair,et al.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.

[122]  David K. Finlay,et al.  Immunometabolism: Cellular Metabolism Turns Immune Regulator* , 2015, The Journal of Biological Chemistry.

[123]  D. Hume,et al.  Aerobic glycolysis and lymphocyte transformation. , 1978, The Biochemical journal.

[124]  J. Licht,et al.  Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.

[125]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[126]  S. Levin,et al.  Regulation of Fyn Through Translocation of Activated Lck into Lipid Rafts , 2003, The Journal of experimental medicine.

[127]  A. Otto Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism , 2016, Cancer & Metabolism.

[128]  G. Glick,et al.  Effector T cells require fatty acid metabolism during murine graft-versus-host disease. , 2013, Blood.

[129]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[130]  D. Hardie,et al.  Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes , 2006, The Journal of experimental medicine.

[131]  M. Pollak,et al.  Metformin directly acts on mitochondria to alter cellular bioenergetics , 2014, Cancer & metabolism.

[132]  F. Carbone,et al.  The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements , 2016, Immunity.

[133]  T. Sparwasser,et al.  Immunometabolism and autoimmunity , 2016, Immunology and cell biology.

[134]  E. Benarroch,et al.  mTOR , 2014, Neurology.

[135]  Gregory A. Wyant,et al.  The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway , 2016, Cell.

[136]  D. Chan,et al.  OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L , 2007, The Journal of cell biology.

[137]  Linda V. Sinclair,et al.  Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy , 2016, Nature Immunology.

[138]  A. Hirao,et al.  PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ. , 2021, Cell reports.

[139]  H. Izzedine,et al.  Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs) , 2014, Clinical kidney journal.

[140]  D. Hardie Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status , 2022 .